{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:57:56Z","timestamp":1791644276960,"version":"4.3.4"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ejps.2023.106451","type":"journal-article","created":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T20:12:50Z","timestamp":1682194370000},"page":"106451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Targeted protein degradation might present a novel therapeutic approach in the fight against African trypanosomiasis"],"prefix":"10.1016","volume":"186","author":[{"given":"Ammar Usman","family":"Danazumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibtida Tabassum","family":"Ishmam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salisu","family":"Idris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matylda Anna","family":"Izert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Oluwadare","family":"Balogun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1769-4542","authenticated-orcid":false,"given":"Maria Wiktoria","family":"G\u00f3rna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2023.106451_bib0001","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1200\/JCO.2006.07.4658","article-title":"What is the right dose? The elusive optimal biologic dose in phase I clinical trials","volume":"24","author":"Adjei","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejps.2023.106451_bib0002","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.molbiopara.2007.07.020","article-title":"Dileucine signal-dependent and AP-1-independent targeting of a lysosomal glycoprotein in Trypanosoma brucei","volume":"156","author":"Allen","year":"2007","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejps.2023.106451_bib0003","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1107\/S1744309106028740","article-title":"Trypanosoma brucei UDP-galactose-4\u2032-epimerase in ternary complex with NAD+ and the substrate analogue UDP-4-deoxy-4-fluoro-\u03b1-d- galactose","volume":"62","author":"Alphey","year":"2006","journal-title":"Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun."},{"key":"10.1016\/j.ejps.2023.106451_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004130","article-title":"Cathepsin-L can resist lysis by human serum in trypanosoma brucei brucei","volume":"10","author":"Alsford","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejps.2023.106451_bib0005","first-page":"1","article-title":"The current drug discovery landscape for trypanosomiasis and leishmaniasis: challenges and strategies to identify drug targets","author":"Altamura","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejps.2023.106451_bib0006","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41586-021-03597-x","article-title":"An invariant Trypanosoma vivax vaccine antigen induces protective immunity","author":"Autheman","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2023.106451_bib0007","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/mmi.12831","article-title":"Molecular basis for the reverse reaction of African human trypanosomes glycerol kinase","volume":"94","author":"Balogun","year":"2014","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ejps.2023.106451_bib0008","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1016\/j.bbagen.2017.07.028","article-title":"Glycerol kinase of African trypanosomes possesses an intrinsic phosphatase activity","volume":"1861","author":"Balogun","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj"},{"key":"10.1016\/j.ejps.2023.106451_bib0009","doi-asserted-by":"crossref","first-page":"13002","DOI":"10.1096\/fj.201901342R","article-title":"Discovery of trypanocidal coumarins with dual inhibition of both the glycerol kinase and alternative oxidase of Trypanosoma brucei brucei","volume":"33","author":"Balogun","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.ejps.2023.106451_bib0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","article-title":"Lysosome-targeting chimaeras for degradation of extracellular proteins","volume":"584","author":"Banik","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2023.106451_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(18)53743-1","article-title":"Glucose catabolism in African trypanosomes. Evidence that the terminal step is catalyzed by a pyruvate transporter capable of facilitating uptake of toxic analogs","author":"Barnard","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0012","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41589-022-01218-w","article-title":"Targeted degradation via direct 26S proteasome recruitment","volume":"19","author":"Bashore","year":"2022","journal-title":"Nature Chem. Biol. 2022"},{"key":"10.1016\/j.ejps.2023.106451_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25081924","article-title":"Targeting trypanothione reductase, a key enzyme in the redox trypanosomatid metabolism, to develop new drugs against leishmaniasis and trypanosomiases","volume":"25","author":"Battista","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2023.106451_bib0014","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fpls.2018.00130","article-title":"Nanobody-directed specific degradation of proteins by the 26s-proteasome in plants","volume":"9","author":"Baudisch","year":"2018","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.ejps.2023.106451_bib0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nature Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2023.106451_bib0016","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/cmdc.201300399","article-title":"Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase\/trypanothione reductase inhibitors against trypanosoma brucei and trypanosoma Cruzi","volume":"9","author":"Belluti","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejps.2023.106451_bib0017","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nsmb.2780","article-title":"New insights into ubiquitin E3 ligase mechanism","volume":"21","author":"Berndsen","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejps.2023.106451_bib0018","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1471-4159.2004.02422.x","article-title":"Glycogen synthase kinase 3: a drug target for CNS therapies","volume":"89","author":"Bhat","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejps.2023.106451_bib0019","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3389\/fchem.2020.630888","article-title":"Ubiquitination and the proteasome as drug targets in trypanosomatid diseases","volume":"8","author":"Bijlmakers","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0020","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41564-022-01295-6","article-title":"Genome-wide subcellular protein map for the flagellate parasite Trypanosoma brucei","volume":"8","author":"Billington","year":"2023","journal-title":"Nature Microbiol."},{"key":"10.1016\/j.ejps.2023.106451_bib0021","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/bj2080435","article-title":"Restriction of bacterial growth by inhibition of polyamine biosynthesis by using monofluoromethylornithine, difluoromethylarginine and dicyclohexylammonium sulphate","volume":"208","author":"Bitonti","year":"1982","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejps.2023.106451_bib0022","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/pim.12387","article-title":"Prospects for vaccination against pathogenic African trypanosomes","volume":"38","author":"Black","year":"2016","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.ejps.2023.106451_bib0023","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrmicro3380","article-title":"Molecular mechanisms of antibiotic resistance","volume":"13","author":"Blair","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejps.2023.106451_bib0024","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/cells1030346","article-title":"Autophagy in Trypanosomatids","volume":"1","author":"Brennand","year":"2012","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.ejps.2023.106451_bib0025","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00915-21","article-title":"Intrabody-Induced Cell Death by Targeting the T. brucei Cytoskeletal Protein Tb BILBO1","volume":"9","author":"Broster Reix","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ejps.2023.106451_bib0026","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3389\/fcell.2022.872729","article-title":"Overcoming cancer drug resistance utilizing PROTAC technology","volume":"10","author":"Burke","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejps.2023.106451_bib0027","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00436-002-0766-5","article-title":"Eflornithine for the treatment of human African trypanosomiasis","volume":"90","author":"Burri","year":"2003","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejps.2023.106451_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004362","article-title":"Efficacy, safety, and dose of pafuramidine, a new oral drug for treatment of first stage sleeping sickness, in a Phase 2a clinical study and Phase 2b randomized clinical studies","volume":"10","author":"Burri","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejps.2023.106451_bib0029","doi-asserted-by":"crossref","DOI":"10.1021\/acs.chemrev.7b00077","article-title":"Small-molecule modulation of protein homeostasis","author":"Burslem","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejps.2023.106451_bib0030","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1006\/bbrc.2000.3996","article-title":"Sensitivity of trypanosomatid protozoa to DFMO and metabolic turnover of ornithine decarboxylase","volume":"279","author":"Carrillo","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejps.2023.106451_bib0031","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.pt.2006.08.007","article-title":"Trypanosome alternative oxidase: from molecule to function","volume":"22","author":"Chaudhuri","year":"2006","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejps.2023.106451_bib0032","first-page":"1339","article-title":"Inducible degradation of oncogenic nucleolin using an aptamer-based PROTAC","volume":"66","author":"Chen","year":"2023","journal-title":"Cite This: J. Med. Chem"},{"key":"10.1016\/j.ejps.2023.106451_bib0033","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.3390\/ijms22126407","article-title":"Hydrophobic tagging-mediated degradation of transcription coactivator src-1","volume":"22","author":"Choi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2023.106451_bib0034","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.chembiol.2016.02.016","article-title":"Specific knockdown of endogenous tau protein by peptide-directed ubiquitin-proteasome degradation","volume":"23","author":"Chu","year":"2016","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejps.2023.106451_bib0035","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nchembio.1869","article-title":"Tunable and reversible drug control of protein production via a self-excising degron","volume":"11","author":"Chung","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejps.2023.106451_bib0036","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1600-0854.2008.00785.x","article-title":"Ubiquitylation is required for degradation of transmembrane surface proteins in Trypanosomes","volume":"9","author":"Chung","year":"2008","journal-title":"Traffic"},{"key":"10.1016\/j.ejps.2023.106451_bib0037","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.7b01272","article-title":"Protac-induced protein degradation in drug discovery: breaking the rules or just making new ones?","author":"Churcher","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0038","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-cancerbio-030617-050430","article-title":"Proteolysis-targeting chimeras: harnessing the ubiquitin-proteasome system to induce degradation of specific target proteins","author":"Coleman","year":"2018","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1016\/j.ejps.2023.106451_bib0039","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.molbiopara.2014.06.004","article-title":"Capturing the variant surface glycoprotein repertoire (the VSGnome) of Trypanosoma brucei Lister 427","volume":"195","author":"Cross","year":"2014","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejps.2023.106451_bib0040","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2174\/0929867324666170120160034","article-title":"A brief review of drug discovery research for human African Trypanosomiasis","volume":"24","author":"Cullen","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.csbj.2022.10.002","article-title":"Immunoinformatic design of a putative multi-epitope vaccine candidate against trypanosoma brucei gambiense","author":"Danazumi","year":"2022","journal-title":"Comput. Struct. Biotechnol. J"},{"key":"10.1016\/j.ejps.2023.106451_bib0042","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1021\/bi001659k","article-title":"The ubiquitin-proteasome pathway plays an essential role in proteolysis during Trypanosoma cruzi remodeling","volume":"40","author":"de Diego","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejps.2023.106451_bib0043","series-title":"Origins and composition of the cullin-RING E3 ligases in trypanosomes. Doctoral Thesis","author":"del Pino","year":"2020"},{"key":"10.1016\/j.ejps.2023.106451_bib0044","article-title":"Prime time for PROTACs","author":"Deshaies","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejps.2023.106451_bib0045","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.meegid.2016.07.041","article-title":"Zoonotic trypanosomes in South East Asia: attempts to control Trypanosoma lewisi using human and animal trypanocidal drugs. Infection","volume":"44","author":"Desquesnes","year":"2016","journal-title":"Genetic. Evol."},{"key":"10.1016\/j.ejps.2023.106451_bib0046","first-page":"1","article-title":"Mistargeting of aggregation prone mitochondrial proteins activates a nucleus-mediated posttranscriptional quality control pathway in trypanosomes","author":"Dewar","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejps.2023.106451_bib0047","doi-asserted-by":"crossref","first-page":"10606","DOI":"10.1021\/acs.jmedchem.1c00895","article-title":"Molecular glues for targeted protein degradation: from serendipity to rational discovery","volume":"64","author":"Dong","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0048","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.4049\/jimmunol.175.4.2501","article-title":"The induction of a Type 1 immune response following a trypanosoma brucei infection is MyD88 dependent","volume":"175","author":"Drennan","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2023.106451_bib0049","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbapap.2004.04.005","article-title":"Erratum: plasmodium falciparum glycogen synthase kinase-3: molecular model, expression, intracellular localisation and selective inhibitors (Biochimica et Biophysica Acta - Proteins and Proteomics (2004) 1697 (181-196) DOI: 10.1016\/j.bbapap.2003.11.023)","volume":"1700","author":"Droucheau","year":"2004","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"key":"10.1016\/j.ejps.2023.106451_bib0050","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1021\/jm100456a","article-title":"Computer-aided identification of trypanosoma brucei uridine diphosphate galactose 4\u0301-epimerase inhibitors: toward the development of novel therapies for African sleeping sickness","volume":"53","author":"Durrant","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/0166-6851(86)90004-6","article-title":"Inhibition of glyceraldehyde-3-phosphate dehydrogenase by pentalenolactone in Trypanosoma brucei","author":"Duszenko","year":"1986","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejps.2023.106451_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.04.030","article-title":"Proteolysis targeting chimeras (PROTACs)in \u2018beyond rule-of-five\u2019 chemical space: recent progress and future challenges","author":"Edmondson","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2023.106451_bib0053","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3109\/14756366.2015.1108972","article-title":"Synthesis and biological evaluation of novel peptidomimetics as rhodesain inhibitors","volume":"31","author":"Ettari","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0054","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1021\/jm301424d","article-title":"Inhibition of rhodesain as a novel therapeutic modality for human African trypanosomiasis","volume":"56","author":"Ettari","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0055","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.pt.2018.04.002","article-title":"Melarsoprol resistance in African trypanosomiasis","volume":"34","author":"Fairlamb","year":"2018","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejps.2023.106451_bib0056","doi-asserted-by":"crossref","DOI":"10.1038\/cr.2013.168","article-title":"The machinery of macroautophagy","author":"Feng","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.ejps.2023.106451_bib0057","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrmicro2221","article-title":"The trypanosome flagellar pocket","volume":"7","author":"Field","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejps.2023.106451_bib0058","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrmicro.2016.193","article-title":"Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need","volume":"15","author":"Field","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejps.2023.106451_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2019.110452","article-title":"Targeting nuclear receptors with PROTAC degraders","volume":"493","author":"Flanagan","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejps.2023.106451_bib0060","doi-asserted-by":"crossref","DOI":"10.1038\/nchembio.2329","article-title":"Structural basis of PROTAC cooperative recognition for selective protein degradation","author":"Gadd","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejps.2023.106451_bib0061","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molbiopara.2010.01.002","article-title":"An internal sequence targets Trypanosoma brucei triosephosphate isomerase to glycosomes","volume":"171","author":"Galland","year":"2010","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejps.2023.106451_bib0062","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1046\/j.1432-1327.1998.2530684.x","article-title":"Sulfhydryl reagent susceptibility in proteins with high sequence similarity: triosephosphate isomerase from Trypanosoma brucei, Trypanosoma cruzi and Leishmania mexicana","volume":"253","author":"Garza-Ramos","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejps.2023.106451_bib0063","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1017\/S0031182016001268","article-title":"The animal trypanosomiases and their chemotherapy: a review","volume":"143","author":"Giordani","year":"2016","journal-title":"Parasitology"},{"key":"10.1016\/j.ejps.2023.106451_bib0064","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/j.bmc.2019.02.048","article-title":"Cereblon versus VHL: hijacking E3 ligases against each other using PROTACs","volume":"27","author":"Girardini","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0065","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1084\/jem.184.5.1909","article-title":"Proteasome activity is required for the stage-specific transformation of a protozoan parasite","volume":"184","author":"Gonz\u00e1lez","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejps.2023.106451_bib0066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0000479","article-title":"Protease activated receptor signaling is required for African trypanosome traversal of human brain microvascular endothelial cells","volume":"3","author":"Grab","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejps.2023.106451_bib0067","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1128\/MCB.15.11.5945","article-title":"Transcriptional regulation of metacyclic variant surface glycoprotein gene expression during the life cycle of Trypanosoma brucei","volume":"15","author":"Graham","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejps.2023.106451_bib0068","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.4161\/hv.7.11.18203","article-title":"Vaccination against trypanosomiasis: can it be done or is the trypanosome truly the ultimate immune destroyer and escape artist?","volume":"7","author":"Greca","year":"2011","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.ejps.2023.106451_bib0069","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/mmi.14849","article-title":"Targeted protein degradation at the host-pathogen interface","volume":"117","author":"Grohmann","year":"2022","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ejps.2023.106451_bib0070","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/j.bbamcr.2013.08.008","article-title":"Ubiquitination of the glycosomal matrix protein receptor PEX5 in Trypanosoma brucei by PEX4 displays novel features","volume":"1833","author":"Gualdr\u00f3n-L\u00f3pez","year":"2013","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ejps.2023.106451_bib0071","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-26532-z","article-title":"Ubiquitin Proteasome pathway proteins as potential drug targets in parasite Trypanosoma cruzi","volume":"8","author":"Gupta","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2023.106451_bib0072","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/nar\/30.1.52","article-title":"Onlined Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders","volume":"30","author":"Hamosh","year":"2002","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.ejps.2023.106451_bib0073","doi-asserted-by":"crossref","first-page":"23299","DOI":"10.1002\/anie.202107347","article-title":"Aptamer-PROTAC conjugates (APCs) for tumor-specific targeting in breast cancer","volume":"60","author":"He","year":"2021","journal-title":"Angewandte Chemie Int. Edit."},{"key":"10.1016\/j.ejps.2023.106451_bib0074","doi-asserted-by":"crossref","first-page":"8206","DOI":"10.1016\/S0021-9258(20)82050-X","article-title":"Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown","volume":"258","author":"Hershko","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0075","first-page":"149","article-title":"Electron transport systems in kinetoplastida","volume":"456","author":"Hill","year":"1976","journal-title":"BBA Rev. Bioenergetic."},{"key":"10.1016\/j.ejps.2023.106451_bib0076","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1073\/pnas.1217206110","article-title":"Posttranslational protein knockdown coupled to receptor tyrosine kinase activation with phosphoPROTACs","volume":"110","author":"Hines","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2023.106451_bib0077","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-18-2918","article-title":"MDM2-recruiting PROTAC offers superior, synergistic antiproliferative activity via simultaneous degradation of BRD4 and stabilization of p53","author":"Hines","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2023.106451_bib0078","doi-asserted-by":"crossref","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejps.2023.106451_bib0079","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006146","article-title":"CRL4WDR1Controls Polo-like kinase protein abundance to promote bilobe duplication, basal body segregation and flagellum attachment in trypanosoma brucei","author":"Hu","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejps.2023.106451_bib0080","article-title":"E3 ligase ligands for PROTACs: how they were found and how to discover new ones","author":"Ishida","year":"2020","journal-title":"SLAS Discovery"},{"key":"10.1016\/j.ejps.2023.106451_bib0081","doi-asserted-by":"crossref","first-page":"175","DOI":"10.12688\/wellcomeopenres.17964.1","article-title":"Targeted protein degradation using deGradFP in Trypanosoma brucei","volume":"7","author":"Ishii","year":"2022","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.ejps.2023.106451_bib0082","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1021\/ja100691p","article-title":"Protein knockdown using methyl bestatin-ligand hybrid molecules: design and synthesis of inducers of ubiquitination-mediated degradation of cellular retinoic acid-binding proteins","volume":"132","author":"Itoh","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2023.106451_bib0083","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fmolb.2021.669762","article-title":"Applications of bacterial degrons and degraders \u2014 toward targeted protein degradation in bacteria","volume":"8","author":"Izert","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejps.2023.106451_bib0084","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/cbdd.12628","article-title":"Screening and identification of inhibitors of trypanosoma brucei cathepsin l with antitrypanosomal activity","volume":"87","author":"Jefferson","year":"2016","journal-title":"Chem. Biol. Drug Des."},{"issue":"4","key":"10.1016\/j.ejps.2023.106451_bib0085","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/1061186X.2023.2185247","article-title":"Albumin-encapsulated HSP90-PROTAC BP3 nanoparticles not only retain protein degradation ability but also enhance the antitumour activity of BP3 in vivo","volume":"31","author":"Jiang","year":"2023","journal-title":"J. Drug. Target."},{"key":"10.1016\/j.ejps.2023.106451_bib0086","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2023.106451_bib0087","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0000701","article-title":"Crystal structures of TbCatB and rhodesain, potential chemotherapeutic targets and major cysteine proteases of Trypanosoma brucei","volume":"4","author":"Kerr","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejps.2023.106451_bib0088","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev.cellbio.22.010605.093503","article-title":"Modification of proteins by ubiquitin and ubiquitin-like proteins","volume":"22","author":"Kerscher","year":"2006","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.ejps.2023.106451_bib0089","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189044","article-title":"Ornithine decarboxylase as a therapeutic target for endometrial cancer","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2023.106451_bib0090","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1038\/sj.onc.1207535","article-title":"Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins","volume":"23","author":"Knockaert","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.ejps.2023.106451_bib0091","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.chembiol.2021.04.009","article-title":"Haven't got a glue: protein surface variation for the design of molecular glue degraders","volume":"28","author":"Kozicka","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejps.2023.106451_bib0092","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1432-1033.1992.tb17069.x","article-title":"Inhibition of triosephosphate isomerase from Trypanosoma brucei with cyclic hexapeptides","volume":"207","author":"Kuntz","year":"1992","journal-title":"Eur. J. Biochem"},{"key":"10.1016\/j.ejps.2023.106451_bib0093","doi-asserted-by":"crossref","DOI":"10.1038\/nrd.2016.211","article-title":"Induced protein degradation: an emerging drug discovery paradigm","author":"Lai","year":"2017","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.ejps.2023.106451_bib0094","article-title":"Modular PROTAC Design for the degradation of oncogenic BCR-ABL","author":"Lai","year":"2016","journal-title":"Angewandte Chemie - Int. Edit."},{"key":"10.1016\/j.ejps.2023.106451_bib0095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.exppara.2010.06.017","article-title":"Trypanosoma brucei: immunisation with plasmid DNA encoding invariant surface glycoprotein gene is able to induce partial protection in experimental African trypanosomiasis","volume":"127","author":"Lan\u00e7a","year":"2011","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejps.2023.106451_bib0096","doi-asserted-by":"crossref","unstructured":"Lebraud, H., Wright, D.J., Johnson, C.N., Heightman, T.D., Pharmaceuticals, A., Park, C.S., 2016. Protein degradation by In-Cell Self-assembly of proteolysis targeting chimeras. 10.1021\/acscentsci.6b00280.","DOI":"10.1021\/acscentsci.6b00280"},{"key":"10.1016\/j.ejps.2023.106451_bib0097","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1021\/cr0101656","article-title":"Human and parasitic Papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design","volume":"102","author":"Lecaille","year":"2002","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejps.2023.106451_bib0098","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1074\/jbc.M002466200","article-title":"Indirubins inhibit glycogen synthase kinase-3\u03b2 and CDK5\/P25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?","volume":"276","author":"Leclerc","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0099","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1128\/EC.05012-11","article-title":"Ubiquitylation and developmental regulation of invariant surface protein expression in trypanosomes","volume":"10","author":"Leung","year":"2011","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.ejps.2023.106451_bib0100","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1462-5822.2012.01795.x","article-title":"A role of autophagy in Trypanosoma brucei cell death","volume":"14","author":"Li","year":"2012","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.ejps.2023.106451_bib0101","article-title":"PROTACs: past, present and future","author":"Li","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejps.2023.106451_bib0102","doi-asserted-by":"crossref","first-page":"15486","DOI":"10.1074\/jbc.M109029200","article-title":"An easily dissociated 26 S proteasome catalyzes an essential ubiquitin-mediated protein degradation pathway in Trypanosoma brucei","volume":"277","author":"Li","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0103","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1021\/jacs.1c00451","article-title":"Cancer selective target degradation by folate-caged PROTACs","volume":"143","author":"Liu","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2023.106451_bib0104","article-title":"Alpha-difluoromethylornithine, an irreversible inhibitor of polyamine biosynthesis, as a therapeutic strategy against hyperproliferative and infectious diseases","author":"LoGiudice","year":"2018","journal-title":"Med. Sci."},{"key":"10.1016\/j.ejps.2023.106451_bib0105","doi-asserted-by":"crossref","first-page":"545","DOI":"10.4269\/ajtmh.1993.49.545","article-title":"The ubiquitin-ligase system in Trypanosoma brucei brucei","volume":"49","author":"Lowrie","year":"1993","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejps.2023.106451_bib0106","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejmech.2018.01.063","article-title":"Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway","volume":"146","author":"Lu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0107","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.7150\/thno.41677","article-title":"A cell-permeable peptide-based PROTAC against the oncoprotein CREPT proficiently inhibits pancreatic cancer","volume":"10","author":"Ma","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ejps.2023.106451_bib0108","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113247","article-title":"Specific non-genetic IAP-based protein erasers (SNIPERs) as a potential therapeutic strategy","volume":"216","author":"Ma","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0109","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201700311R","article-title":"Ornithine uptake and the modulation of drug sensitivity in Trypanosoma brucei","author":"Macedo","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.ejps.2023.106451_bib0110","doi-asserted-by":"crossref","first-page":"48426","DOI":"10.1074\/jbc.M402470200","article-title":"A cathepsin B-like protease is required for host protein degradation in Trypanosoma brucei","volume":"279","author":"Mackey","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0111","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00954-1","article-title":"Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation","volume":"8","author":"Maniaci","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejps.2023.106451_bib0112","doi-asserted-by":"crossref","DOI":"10.1039\/C9MD00272C","article-title":"Developing degraders: principles and perspectives on design and chemical space","author":"Maple","year":"2019","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejps.2023.106451_bib0113","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.drudis.2015.02.004","article-title":"Cruzain inhibitors: efforts made, current leads and a structural outlook of new hits","volume":"20","author":"Martinez-Mayorga","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2023.106451_bib0114","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41589-020-0594-x","article-title":"Rational discovery of molecular glue degraders via scalable chemical profiling","author":"Mayor-Ruiz","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejps.2023.106451_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2015.08.074","article-title":"Identification of non-peptidic cysteine reactive fragments as inhibitors of cysteine protease rhodesain","author":"McShan","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2023.106451_bib0116","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tips.2004.07.006","article-title":"Pharmacological inhibitors of glycogen synthase kinase 3","volume":"25","author":"Meijer","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejps.2023.106451_bib0117","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0166-6851(96)02665-5","article-title":"An antibiotic, ascofuranone, specifically inhibits respiration and in vitro growth of long slender bloodstream forms of Trypanosoma brucei brucei","volume":"81","author":"Minagawa","year":"1996","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejps.2023.106451_bib0118","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0264-410X(95)93128-V","article-title":"Partial protection against natural trypanosomiasis after vaccination with a flagellar pocket antigen from Trypanosoma brucei rhodesiense","volume":"13","author":"Mkunza","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.ejps.2023.106451_bib0119","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.cell.2022.05.009","article-title":"BacPROTACs mediate targeted protein degradation in bacteria","volume":"185","author":"Morreale","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ejps.2023.106451_bib0120","article-title":"Insights into the control and management of human and bovine african trypanosomiasis in zambia between 2009 and 2019-a review","volume":"5","author":"Mulenga","year":"2020","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.ejps.2023.106451_bib0121","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/141526","article-title":"Role of the ubiquitin-proteasome systems in the biology and virulence of protozoan parasites","volume":"2015","author":"Mu\u00f1oz","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ejps.2023.106451_bib0122","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies: natural single-domain antibodies","volume":"82","author":"Muyldermans","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejps.2023.106451_bib0123","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41589-018-0021-8","article-title":"The dTAG system for immediate and target-specific protein degradation","volume":"14","author":"Nabet","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejps.2023.106451_bib0124","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ddtec.2018.12.002","article-title":"SNIPERs-Hijacking IAP activity to induce protein degradation","volume":"31","author":"Naito","year":"2019","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejps.2023.106451_bib0125","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.7_suppl.259","article-title":"ARV-110: an oral androgen receptor PROTAC degrader for prostate cancer","author":"Neklesa","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejps.2023.106451_bib0126","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nchembio.597","article-title":"Small-molecule hydrophobic tagging induced degradation of HaloTag fusion proteins","volume":"7","author":"Neklesa","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejps.2023.106451_bib0127","doi-asserted-by":"crossref","first-page":"9500","DOI":"10.1021\/acsami.0c05750","article-title":"Recent progress in aptamer discoveries and modifications for therapeutic applications","volume":"13","author":"Ni","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejps.2023.106451_bib0128","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1172\/JCI27798C1","article-title":"Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine protease (Journal of Clinical Investigation (2006) 116, (2739-2747) DOI:10.1172\/JCI27798)","volume":"118","author":"Nikolskaia","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2023.106451_bib0129","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nmeth.1401","article-title":"An auxin-based degron system for the rapid depletion of proteins in nonplant cells","volume":"6","author":"Nishimura","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejps.2023.106451_bib0130","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1074\/jbc.M116.768853","article-title":"In vivo knockdown of pathogenic proteins via specific and nongenetic inhibitor of apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs)","volume":"292","author":"Ohoka","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0131","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.molbiopara.2010.12.009","article-title":"Structure determination of glycogen synthase kinase-3 from Leishmania major and comparative inhibitor structure-activity relationships with Trypanosoma brucei GSK-3","volume":"176","author":"Ojo","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejps.2023.106451_bib0132","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1128\/AAC.00364-08","article-title":"Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy","volume":"52","author":"Ojo","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2023.106451_bib0133","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1432-1033.1983.tb07140.x","article-title":"Glycogen synthase from rabbit skeletal muscle; effect of insulin on the state of phosphorylation of the Seven Phosphoserine Residues in vivo","volume":"130","author":"Parker","year":"1983","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejps.2023.106451_bib0134","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1021\/acscentsci.9b00713","article-title":"Reversible spatiotemporal control of induced protein degradation by bistable PhotoPROTACs","volume":"5","author":"Pfaff","year":"2019","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.ejps.2023.106451_bib0135","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.TM118.003342","article-title":"Polyamines in protozoan pathogens","author":"Phillips","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0136","first-page":"147","article-title":"Glycogen synthase kinase-3: functions in oncogenesis and development","volume":"1114","author":"Plyte","year":"1992","journal-title":"BBA - Rev. Cancer"},{"key":"10.1016\/j.ejps.2023.106451_bib0137","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1021\/acsinfecdis.1c00203","article-title":"Targeted protein degradation: the new frontier of antimicrobial discovery?","volume":"7","author":"Powell","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejps.2023.106451_bib0138","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial","volume":"374","author":"Priotto","year":"2009","journal-title":"The Lancet"},{"key":"10.1016\/j.ejps.2023.106451_bib0139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000078","article-title":"Trypanosomiasis-induced B cell apoptosis results in loss of protective anti-parasite antibody responses and abolishment of vaccine-induced memory responses","volume":"4","author":"Radwanska","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejps.2023.106451_bib0140","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1073\/pnas.1521738113","article-title":"PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer","volume":"113","author":"Raina","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2023.106451_bib0141","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1021\/acsinfecdis.8b00355","article-title":"Pyrrolopyrimidine vs imidazole-phenyl-thiazole scaffolds in nonpeptidic dimerization inhibitors of leishmania infantum trypanothione reductase","volume":"5","author":"Revuelto","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejps.2023.106451_bib0142","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay5064","article-title":"PHOTACs enable optical control of protein degradation","volume":"6","author":"Reynders","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejps.2023.106451_bib0143","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2337\/diabetes.52.3.588","article-title":"Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo","volume":"52","author":"Ring","year":"2003","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.ejps.2023.106451_bib191","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005626","article-title":"The ubiquitin-conjugating enzyme CDC34 is essential for cytokinesis in contrast to putative subunits of a SCF complex in Trypanosoma brucei","volume":"11","author":"Rojas","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ejps.2023.106451_bib0144","doi-asserted-by":"crossref","first-page":"19728","DOI":"10.1074\/jbc.M502370200","article-title":"The suppression of galactose metabolism in procylic form Trypanosoma brucei causes cessation of cell growth and alters procyclin glycoprotein structure and copy number","volume":"280","author":"Roper","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0145","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1073\/pnas.092669999","article-title":"Galactose metabolism is essential for the African sleeping sickness parasite Trypanosoma brucei","volume":"99","author":"Roper","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2023.106451_bib0146","doi-asserted-by":"crossref","DOI":"10.1021\/acschembio.9b00092","article-title":"SPR-measured dissociation kinetics of PROTAC ternary complexes influence target degradation rate","author":"Roy","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejps.2023.106451_bib0147","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1074\/mcp.T300009-MCP200","article-title":"Development of Protacs to target cancer-promoting proteins for ubiquitination and degradation","volume":"2","author":"Sakamoto","year":"2003","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ejps.2023.106451_bib0148","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2023.106451_bib0149","doi-asserted-by":"crossref","DOI":"10.1038\/s41573-019-0047-y","article-title":"Targeted protein degradation: expanding the toolbox","author":"Schapira","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2023.106451_bib0150","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1021\/jacs.6b03052","article-title":"Quantum chemical-based protocol for the rational design of covalent inhibitors","volume":"138","author":"Schirmeister","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2023.106451_bib0151","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1432-1033.1991.tb16114.x","article-title":"Probing the catalytic sites of triosephosphate isomerase by 31P-NMR with reversibly and irreversibly binding substrate analogues","volume":"199","author":"Schnackerz","year":"1991","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejps.2023.106451_bib0152","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1016\/j.bmcl.2008.07.114","article-title":"Targeted intracellular protein degradation induced by a small molecule: en route to chemical proteomics","volume":"18","author":"Schneekloth","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2023.106451_bib0153","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0166-6851(96)02599-6","article-title":"Purification and characterization of proteasomes from Trypanosoma brucei","volume":"78","author":"Shao-Bing","year":"1996","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejps.2023.106451_bib0154","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0166-6851(02)00243-8","article-title":"High-resolution crystal structure of Trypanosoma brucei UDP-galactose 4\u2032-epimerase: a potential target for structure-based development of novel trypanocides","volume":"126","author":"Shaw","year":"2003","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejps.2023.106451_bib0155","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1021\/acschembio.6b00656","article-title":"Boc3Arg-linked ligands induce degradation by localizing target proteins to the 20S proteasome","volume":"11","author":"Shi","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejps.2023.106451_bib0156","doi-asserted-by":"crossref","first-page":"14269","DOI":"10.1038\/srep14269","article-title":"Nanobody-targeted E3-ubiquitin ligase complex degrades nuclear proteins","volume":"5","author":"Shin","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2023.106451_bib0157","unstructured":"Short, S.K., Growth, T., 2019. crossm Indirubin Analogues Inhibit Trypanosoma brucei Glycogen 63, 1\u201318."},{"key":"10.1016\/j.ejps.2023.106451_bib0158","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001859","article-title":"Estimating and mapping the population at risk of sleeping sickness","volume":"6","author":"Simarro","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejps.2023.106451_bib0159","first-page":"1","article-title":"Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase","author":"Smith","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejps.2023.106451_bib0160","doi-asserted-by":"crossref","first-page":"16771","DOI":"10.1074\/jbc.M109.081588","article-title":"Discovery of potent and selective inhibitors of Trypanosoma brucei ornithine decarboxylase","volume":"285","author":"Smithson","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0161","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1021\/acschembio.8b00693","article-title":"Homo-PROTACs for the chemical knockdown of cereblon","volume":"13","author":"Steinebach","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejps.2023.106451_bib0162","doi-asserted-by":"crossref","DOI":"10.1016\/j.molbiopara.2019.111246","article-title":"Trypanosoma brucei: inhibition of cathepsin L is sufficient to kill bloodstream forms","volume":"235","author":"Steverding","year":"2020","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejps.2023.106451_bib0163","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ijpara.2012.03.009","article-title":"Trypanosoma brucei: chemical evidence that cathepsin L is essential for survival and a relevant drug target","volume":"42","author":"Steverding","year":"2012","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejps.2023.106451_bib0164","article-title":"Protacs: great opportunities for academia and industry","volume":"4","author":"Sun","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejps.2023.106451_bib0165","article-title":"Lysine-deficient proteome can be regulated through non-canonical ubiquitination and ubiquitin-independent proteasomal degradation","author":"Szulc","year":"2023","journal-title":"Biorxiv"},{"key":"10.1016\/j.ejps.2023.106451_bib0166","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2019.09.009","article-title":"AUTACs: cargo-specific degraders using selective autophagy","volume":"76","author":"Takahashi","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejps.2023.106451_bib0167","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2183\/pjab.85.12","article-title":"The proteasome: overview of structure and functions","volume":"85","author":"Tanaka","year":"2009","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.ejps.2023.106451_bib0168","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1021\/acs.jmedchem.9b01741","article-title":"Selectivity and physicochemical optimization of repurposed Pyrazolo[1,5- b]pyridazines for the treatment of human African trypanosomiasis","volume":"63","author":"Tear","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0169","doi-asserted-by":"crossref","DOI":"10.1093\/emboj\/19.1.94","article-title":"Recognition of the polyubiquitin proteolytic signal","author":"Thrower","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.ejps.2023.106451_bib0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116221","article-title":"In vivo synthetic chemistry of proteolysis targeting chimeras (PROTACs)","volume":"41","author":"Tomoshige","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0171","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/anie.201507978","article-title":"Small-molecule PROTACS: new approaches to protein degradation","volume":"55","author":"Toure","year":"2016","journal-title":"Angewandte Chemie - Int. Edit."},{"key":"10.1016\/j.ejps.2023.106451_bib0172","doi-asserted-by":"crossref","DOI":"10.37349\/etat.2020.00018","article-title":"Current strategies for the design of PROTAC linkers: a critical review","author":"Troup","year":"2020","journal-title":"Explor Target Antitumor Ther."},{"key":"10.1016\/j.ejps.2023.106451_bib0173","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbapap.2011.10.002","article-title":"Cysteine cathepsins: from structure, function and regulation to new frontiers","volume":"1824","author":"Turk","year":"2012","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"10.1016\/j.ejps.2023.106451_bib0174","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-019-3680-8","article-title":"Identification of Trypanosoma brucei gambiense in naturally infected dogs in Nigeria","volume":"12","author":"Umeakuana","year":"2019","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.ejps.2023.106451_bib0175","unstructured":"UniProt, n.d. CULT domain-containing protein - Trypanosoma brucei gambiense (strain MHOM\/CI\/86\/DAL972) | UniProtKB | UniProt [WWW Document]. URL https:\/\/www.uniprot.org\/uniprotkb\/D0A9D4\/entry (accessed 1.24.23)."},{"key":"10.1016\/j.ejps.2023.106451_bib0176","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1016\/j.bmcl.2006.08.091","article-title":"Identification of novel inhibitors of UDP-Glc 4\u2032-epimerase, a validated drug target for african sleeping sickness","volume":"16","author":"Urbaniak","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2023.106451_bib0177","doi-asserted-by":"crossref","first-page":"7536","DOI":"10.1021\/jm500239b","article-title":"The design and synthesis of potent and selective inhibitors of trypanosoma brucei glycogen synthase kinase 3 for the treatment of human African trypanosomiasis","volume":"57","author":"Urich","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2023.106451_bib0178","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22122055","article-title":"Species-specific inactivation of triosephosphate isomerase from trypanosoma brucei: kinetic and molecular dynamics studies","volume":"22","author":"V\u00e1zquez-Raygoza","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2023.106451_bib0179","doi-asserted-by":"crossref","first-page":"139","DOI":"10.14334\/wartazoa.v28i3.1835","article-title":"Surra: trypanosomiasis in livestock is potential as zoonotic disease","volume":"28","author":"Wardhana","year":"2018","journal-title":"Indonesian Bull. Anim. Vet. Sci."},{"key":"10.1016\/j.ejps.2023.106451_bib0180","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cmi.2015.04.011","article-title":"The neglected zoonoses-the case for integrated control and advocacy","volume":"21","author":"Welburn","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejps.2023.106451_bib0181","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.aab1433","article-title":"Selective target protein degradation via phthalimide conjugation","volume":"348","author":"Winter","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ejps.2023.106451_bib0182","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0166-6851(89)90111-4","article-title":"A polyubiquitin gene from Trypanosoma brucei","volume":"37","author":"Wong","year":"1989","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejps.2023.106451_bib0183","series-title":"Trypanosomiasis, Human African (sleeping sickness)","year":"2020"},{"key":"10.1016\/j.ejps.2023.106451_bib0184","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1172\/JCI26251","article-title":"Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function","volume":"115","author":"Wright","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2023.106451_bib0185","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.ijpara.2009.04.005","article-title":"6-Br-5methylindirubin-3\u2032oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: exploitation of GSK-3 for treating leishmaniasis","volume":"39","author":"Xingi","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejps.2023.106451_bib0186","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.parint.2005.09.003","article-title":"Chemotherapeutic efficacy of ascofuranone in Trypanosoma vivax-infected mice without glycerol","volume":"55","author":"Yabu","year":"2006","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ejps.2023.106451_bib0187","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1021\/acschembio.5b00216","article-title":"Selective small molecule induced degradation of the BET Bromodomain protein BRD4","volume":"10","author":"Zengerle","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejps.2023.106451_bib0188","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.omtn.2022.09.008","article-title":"Development of a novel PROTAC using the nucleic acid aptamer as a targeting ligand for tumor selective degradation of nucleolin","volume":"30","author":"Zhang","year":"2022","journal-title":"Mol. Ther. Nucl.Acids"},{"key":"10.1016\/j.ejps.2023.106451_bib0189","doi-asserted-by":"crossref","DOI":"10.1128\/EC.00263-12","article-title":"Role of cytosolic glyceraldehyde-3-phosphate dehydrogenase in visceral organ infection by Leishmania donovani","author":"Zhang","year":"2013","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.ejps.2023.106451_bib0190","first-page":"1","article-title":"Modulation of the surface proteome through multiple ubiquitylation pathways in African trypanosomes","volume":"11","author":"Zoltner","year":"2015","journal-title":"PLoS Pathog."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723000817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723000817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:05:47Z","timestamp":1760529947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098723000817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":191,"alternative-id":["S0928098723000817"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106451","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted protein degradation might present a novel therapeutic approach in the fight against African trypanosomiasis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106451","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106451"}}